Related Experiment Videos
Mitochondria and ischemia/reperfusion injury
Henry M Honda1, Paavo Korge, James N Weiss
1Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California 90095, USA.
Annals of the New York Academy of Sciences
|August 12, 2005
Summary
Cardiac ischemia/reperfusion injury involves mitochondrial permeability transition (MPT). This process, occurring in two phases during ischemia and reperfusion, can lead to cell death. Strategies like pharmacologic preconditioning can protect mitochondria.
Area of Science:
- Cardiovascular Science
- Mitochondrial Biology
- Cellular Physiology
Background:
- Cardiac ischemia/reperfusion (I/R) injury causes cell death through apoptosis and necrosis.
- Mitochondria are central to cell survival, regulating ATP production and programmed cell death.
- Mitochondrial permeability transition (MPT) is a key mechanism of mitochondrial injury during reperfusion.
Purpose of the Study:
- To investigate the two-phase mechanism of MPT during cardiac I/R injury.
- To explore the role of mitochondrial dysfunction in I/R-induced cell death.
- To examine protective strategies against I/R injury by targeting mitochondrial recovery.
Main Methods:
- Hypothesized a two-phase model for I/R-induced MPT: priming during ischemia and triggering at reperfusion.
- Analyzed factors influencing MPT, including inner mitochondrial membrane leak, electron transport, fatty acid accumulation, and cytochrome c loss.
- Investigated the role of mitochondrial membrane potential (ΔΨm), matrix Ca2+, ROS, and pH in MPT triggering.
- Evaluated the effects of pharmacologic preconditioning (e.g., diazoxide) on mitochondrial recovery.
Main Results:
- Ischemia promotes MPT through progressive inner mitochondrial membrane leak and depressed electron transport.
- Reperfusion triggers MPT via complex interactions of ΔΨm, matrix Ca2+, ROS, and pH.
- Pharmacologic preconditioning with diazoxide facilitates mitochondrial recovery by regulating matrix volume and ΔΨm.
- Successful mitochondrial recovery improves ATP synthesis and prevents cytochrome c loss, mitigating MPT.
Conclusions:
- Cardiac I/R injury involves a biphasic MPT process, with priming during ischemia and triggering at reperfusion.
- Mitochondrial dysfunction, particularly MPT, is critical in determining cell fate after I/R.
- Pharmacologic preconditioning strategies can protect the heart by promoting mitochondrial recovery and preventing MPT-induced cell death.